Maspin in the Cornea

角膜内的 Maspin

基本信息

  • 批准号:
    6508796
  • 负责人:
  • 金额:
    $ 28.78万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-08-01 至 2006-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): bMaspin is a member of the serine proteinase inhibitor superfamily that has been studied primarily for its tumor suppressor function in carcinoma cells. Like many epithelial cells, normal corneal epithelial and endothelial cells synthesize maspin. Surprisingly, normal human corneal stromal cells also synthesize maspin, the only non-epithelial cell type known to synthesize this molecule. In culture, as passaged corneal stromal cells develop properties resembling wound fibroblasts, they lose their ability to synthesize maspin, reminiscent of the loss by metastatic carcinoma cells. However, corneal stromal fibroblasts respond to treatment with exogenous maspin by increased adhesion to types I and IV collagens, fibronectin and laminin. Studying maspin's function in the cornea is particularly important since its ability to regulate matrix attachment and cell motility may play a critical role in such events as regulation of stromal wound healing and prevention of tumorigenesis and angiogenesis. This proposal specifically addresses the hypothesis that the increase in adhesion of corneal stromal fibroblasts to type I and type IV collagens, laminin and fibronectin requires multiple domains of maspin and is initiated by maspin binding to a cell surface molecule. The major goal of this project is to identify the regions of the maspin molecule required for its biological activity and to characterize maspin binding partner(s) on corneal stromal fibroblasts. The aims of this proposal are the following: 1) To determine which regions of maspin are required for the induction of increased adhesion of cultured human stromal fibroblasts to ECM molecules. The functional maspin domains will be explored using rMaspin-ovalbumin hybrid proteins, site-specific maspin mutants, peptides and/or antibodies to specific maspin epitopes. 2) To characterize maspin binding to human corneal stromal fibroblasts and selected ECM molecules and determine which region(s) of maspin is required for binding. Maspin interaction with corneal stromal cells and selected ECM molecules will be characterized and the maspin domains determined by focusing on the loss-of-function maspin-ovalbumin hybrids and the results confirmed using maspin binding site peptides. 3) To identify and characterize the maspin-binding molecule(s) on corneal stromal fibroblast membranes. Maspin binding proteins(s) will be isolated by maspin cross-linking and their proteolytic peptides identified by MALDI-TOF analysis and/or N-terminal sequence analysis. They will be cloned, expressed in a yeast system and their interactions with maspin characterized using pull down assays and cross-linking studies.
描述(由申请人提供):bMaspin是丝氨酸蛋白酶抑制剂超家族的成员,主要研究其在癌细胞中的肿瘤抑制功能。和许多上皮细胞一样,正常角膜上皮细胞和内皮细胞也能合成巨噬蛋白。令人惊讶的是,正常的人类角膜基质细胞也能合成maspin,这是已知唯一能合成这种分子的非上皮细胞类型。在培养中,当传代的角膜基质细胞发展出类似创面成纤维细胞的特性时,它们失去了合成巨噬蛋白的能力,这让人想起转移癌细胞的丧失。然而,角膜基质成纤维细胞对外源性巨噬蛋白的反应是通过增加对I型和IV型胶原、纤维连接蛋白和层粘连蛋白的粘附。研究maspin在角膜中的功能尤为重要,因为它调节基质附着和细胞运动的能力可能在调节基质伤口愈合和预防肿瘤发生和血管生成等事件中发挥关键作用。这一建议特别提出了一个假设,即角膜基质成纤维细胞对I型和IV型胶原、层粘连蛋白和纤维连接蛋白的粘附增加需要masmasin的多个结构域,并且是由masmasin与细胞表面分子结合引发的。该项目的主要目标是确定maspin分子的生物活性所需的区域,并表征maspin在角膜间质成纤维细胞上的结合伙伴。这项建议的目的如下:

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sally S. Twining其他文献

Large scale separation of protease inhibitors from malignant human breast tissue
  • DOI:
    10.1007/bf00280275
  • 发表时间:
    1977-01-01
  • 期刊:
  • 影响因子:
    3.700
  • 作者:
    Sally S. Twining;Arthur S. Brecher
  • 通讯作者:
    Arthur S. Brecher
Genetic control of immune response to sperm whale myoglobin in mice. II. T lymphocyte proliferative response to the synthetic antigenic sites.
小鼠抹香鲸肌红蛋白免疫反应的基因控制。
  • DOI:
  • 发表时间:
    1979
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    K. Okuda;Sally S. Twining;C. David;M. Atassi
  • 通讯作者:
    M. Atassi

Sally S. Twining的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sally S. Twining', 18)}}的其他基金

Effect of Maspin on Corneal Heme-and lymph- angiogenesis
Maspin 对角膜血红素和淋巴管生成的影响
  • 批准号:
    8303225
  • 财政年份:
    2011
  • 资助金额:
    $ 28.78万
  • 项目类别:
Effect of Maspin on Corneal Heme-and lymph- angiogenesis
Maspin 对角膜血红素和淋巴管生成的影响
  • 批准号:
    8500301
  • 财政年份:
    2011
  • 资助金额:
    $ 28.78万
  • 项目类别:
Effect of Maspin on Corneal Heme-and lymph- angiogenesis
Maspin 对角膜血红素和淋巴管生成的影响
  • 批准号:
    8187367
  • 财政年份:
    2011
  • 资助金额:
    $ 28.78万
  • 项目类别:
Effect of Maspin on Corneal Heme-and lymph- angiogenesis
Maspin 对角膜血红素和淋巴管生成的影响
  • 批准号:
    8669978
  • 财政年份:
    2011
  • 资助金额:
    $ 28.78万
  • 项目类别:
Maspin in the Cornea
角膜内的 Maspin
  • 批准号:
    6929002
  • 财政年份:
    2002
  • 资助金额:
    $ 28.78万
  • 项目类别:
Maspin in the Cornea
角膜内的 Maspin
  • 批准号:
    6784553
  • 财政年份:
    2002
  • 资助金额:
    $ 28.78万
  • 项目类别:
Maspin in the Cornea
角膜内的 Maspin
  • 批准号:
    6631459
  • 财政年份:
    2002
  • 资助金额:
    $ 28.78万
  • 项目类别:
PROTEASES AND CORNEAL ULCERATION
蛋白酶和角膜溃疡
  • 批准号:
    6525010
  • 财政年份:
    1999
  • 资助金额:
    $ 28.78万
  • 项目类别:
PROTEASES AND CORNEAL ULCERATION
蛋白酶和角膜溃疡
  • 批准号:
    2902261
  • 财政年份:
    1999
  • 资助金额:
    $ 28.78万
  • 项目类别:
Proteases in the Cornea
角膜中的蛋白酶
  • 批准号:
    7207795
  • 财政年份:
    1999
  • 资助金额:
    $ 28.78万
  • 项目类别:

相似海外基金

Bridging the Gap: Next-Gen Tools for Accurate Prediction of Disordered Protein Binding Sites
弥合差距:准确预测无序蛋白质结合位点的下一代工具
  • 批准号:
    24K15172
  • 财政年份:
    2024
  • 资助金额:
    $ 28.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Design of protein crystal templates with multiple binding sites for tracking metal complex reactions.
设计具有多个结合位点的蛋白质晶体模板,用于跟踪金属络合物反应。
  • 批准号:
    23K04928
  • 财政年份:
    2023
  • 资助金额:
    $ 28.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Dynamic changes in PIP2 binding sites and their impact on axonal targeting and function of epilepsy-associated KCNQ/Kv7 channels
PIP2 结合位点的动态变化及其对癫痫相关 KCNQ/Kv7 通道的轴突靶向和功能的影响
  • 批准号:
    10744934
  • 财政年份:
    2023
  • 资助金额:
    $ 28.78万
  • 项目类别:
Computational methods to identify small molecule RNA binding sites
识别小分子 RNA 结合位点的计算方法
  • 批准号:
    573688-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 28.78万
  • 项目类别:
    University Undergraduate Student Research Awards
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
  • 批准号:
    10704557
  • 财政年份:
    2022
  • 资助金额:
    $ 28.78万
  • 项目类别:
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
  • 批准号:
    10537846
  • 财政年份:
    2022
  • 资助金额:
    $ 28.78万
  • 项目类别:
Identifying new types of inhibitors in quinone binding sites in photosynthetic enzymes
鉴定光合酶醌结合位点的新型抑制剂
  • 批准号:
    2753921
  • 财政年份:
    2022
  • 资助金额:
    $ 28.78万
  • 项目类别:
    Studentship
Development of broad nanovaccines targeting diverse coronavirus receptor-binding sites
开发针对不同冠状病毒受体结合位点的广泛纳米疫苗
  • 批准号:
    10328140
  • 财政年份:
    2022
  • 资助金额:
    $ 28.78万
  • 项目类别:
Exploiting Water Network Perturbations in Protein Binding Sites
利用蛋白质结合位点的水网络扰动
  • 批准号:
    10621368
  • 财政年份:
    2021
  • 资助金额:
    $ 28.78万
  • 项目类别:
SBIR Phase I: Nonlinear optical method for identifying protein-ligand binding sites
SBIR 第一阶段:识别蛋白质-配体结合位点的非线性光学方法
  • 批准号:
    2111821
  • 财政年份:
    2021
  • 资助金额:
    $ 28.78万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了